新辅助剂与辅助剂放射治疗可切除局部晚期胃癌:A SEER人口分析
Guangrong Yang1, Qiao Yang2, Lin Cui3
1Department of Oncology, The People's Hospital of Qijiang District, Chongqing 401420, China.
Heliyon
|February 15, 2024
概括
对于可切除的局部晚期胃癌 (LAGC),辅助放射治疗 (RT) 提供了比新辅助RT更大的生存益处. 这一发现表明辅助RT是特定患者亚组的优越治疗选择.
科学领域:
- 在瘤学瘤学.
- 辐射瘤学 辐射瘤学
- 手术瘤学手术瘤学
背景情况:
- 关于新辅助剂与辅助剂放射治疗 (RT) 在可切除局部晚期胃癌 (LAGC) 的疗效的证据有限.
- 胃癌治疗决策需要仔细考虑RT时间,以优化患者的治疗结果.
研究的目的:
- 在可切除局部晚期胃癌 (LAGC) 患者中,比较新辅助与辅助RT的生存结果.
- 确定LAGC患者的特定亚组,与新辅助RT相比,他们可能从辅助RT中获益更多.
主要方法:
- 从SEER数据库 (2004-2015) 中对4790名手术治疗的LAGC患者进行了回顾性分析.
- 卡普兰-梅尔分析和日志等级测试用于生存比较.
- 单变Cox回归用于确定危险比率 (HR) 和置信区间 (CI).
主要成果:
- 与新辅助RT相比,辅助RT在肠道 (49个月与36个月) 和扩散 (32个月与26个月) 亚型中显示出更高的癌症特异生存率 (mCSS) 中位数.
- 特定的子组,包括肠道T1-2N+,T3N-,T3N+和扩散T1-2N+,T3N+患者,从辅助RT中获得更大的益处.
- 辅助性RT还在65岁以上的扩散亚型患者和女性以及在T4N+患者的倾向性得分匹配后显示出生存优势.
结论:
- 辅助RT为T1-2N+,T3N和T3N+临床子组内的可切除LAGC患者提供了比新辅助RT更显著的生存益处.
- 这些发现支持对这些特定患者群体考虑辅助RT而不是新辅助RT.
- 未来的临床试验有必要进一步验证这些结果,并完善LAGC的治疗策略.
更多相关视频
03:32Single Incision Plus One Port Laparoscopic Proximal Gastrectomy with Double Channel Anastomosis for Gastric Cancer Treatment
Published on: December 27, 2024
702
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
11.1K
相关概念视频
Cancer Survival Analysis
346
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
346
Comparing the Survival Analysis of Two or More Groups
186
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
186
